| Bioactivity | N6-(4-Hydroxybenzyl)adenosine is a inhibitor of platelet aggregation induced in vitro by collagen and their activity range was demonstrated (IC50: 6.77-141 μM). IC50 value: 6.77-141 μMTarget: P2Y12receptorAnti-aggregation activity of N6-(4-Hydroxybenzyl)adenosine could involve an interaction with the P2Y12receptor binding site. | ||||||||||||
| Name | N6-(4-Hydroxybenzyl)adenosine | ||||||||||||
| CAS | 110505-75-4 | ||||||||||||
| Formula | C17H19N5O5 | ||||||||||||
| Molar Mass | 373.36 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Vistoli G, et al. Naturally occurring N(6)-substituted adenosines (cytokinin ribosides) are in vitro inhibitors of platelet aggregation: an in silico evaluation of their interaction with the P2Y(12) receptor. Bioorg Med Chem Lett. 2014 Dec 15;24(24):5652- |
N6-(4-Hydroxybenzyl)adenosine
CAS: 110505-75-4 F: C17H19N5O5 W: 373.36
N6-(4-Hydroxybenzyl)adenosine is a inhibitor of platelet aggregation induced in vitro by collagen and their activity ran
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.